Lineage LINE 深 滬
已收盤 08-07 16:00:00 美东时间
42.36
+1.720
+4.23%
華盛通- 最 高42.55
- 今 開40.85
- 成交量 127.83万股
- 最 低 40.37
- 昨 收 40.64
- 總市值 96.46亿
- 52周最高 45.75
- 市盈率 靜 --
- 換手率 0.56%
- 52周最低 30.265
- 委 比 87.55%
- 總股本 2.28亿
- 歷史最高 85.7675
- 量 比 1.27
- 振 幅 5.36%
- 歷史最低 30.265
- 每 手 1
- 風險率 3.45%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Martha Stewart On Why The Right Builder Makes All The Difference
Martha Stewart partnered with Trex Company to transform outdoor spaces at her Bedford, New York, and Seal Harbor, Maine, properties using Trex decking products. She emphasizes the importance of choosing the right contractor, highlighting the expertise and collaboration of TrexPro® builders. Stewart shares tips for selecting a decking contractor, including having a clear vision, thorough research, detailed estimates, and ensuring compliance with b...
08-06 13:59
财报速睇 | Lineage 2026财年Q2营收13.61亿美元，同比增长0.8%；归母净利润亏损0.29亿美元，同比亏损扩大383.3%
华盛资讯8月5日讯，Lineage公布2026财年Q2业绩，公司Q2营收13.61亿美元，同比增长0.8%，归母净利润亏损0.29亿美元，同比亏损扩大383.3%。
08-05 20:04
Lineage Q2 EPS $(0.13) Beats $(0.16) Estimate, Sales $1.361B Miss $1.362B Estimate
Lineage (NASDAQ:LINE) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.16) by 18.75 percent. This is a 333.33 percent decrease over losses of $(0.03) per share from the same period last year. The company reported quarterly sales of $1.361 billion which ...
08-05 18:01
美股大行评级 | 最高1400美元！花旗、大小摩8家大行上调希捷科技目标价；大行集中调整目标价：康宁、科斯塔、思佳讯遭下调，PayPal、Visa、可口可乐、赛莱默获上调
今日重点评级关注：古根海姆：维持ProMIS Neurosciences"买入"评级，目标价从35美元升至69美元；BTIG：维持Cullinan Therapeutics"买入"评级，目标价从38美元升至39美元
07-30 11:45
This CarMax Analyst Is No Longer Bearish; Here Are Top 4 Upgrades For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. JP Morgan analyst Rajat Gupta upgraded Carmax Inc (NYSE:KMX) from Underweight to Neutral and rais...
07-29 20:39
Mizuho Upgrades Lineage to Outperform, Raises Price Target to $47
Mizuho analyst Vikram Malhotra upgrades Lineage (NASDAQ:LINE) from Neutral to Outperform and raises the price target from $40 to $47.
07-29 18:48
美股大行评级 | 富国银行上调亚马逊目标价从313美元升至322美元；潜在涨幅370.99%！HC Wainwright上调Greenwich LifeSciences目标价至69美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Greenwich LifeSciences"买入"评级，目标价从50美元升至69美元；高盛：维持Taysha Gene Therapies"买入"评级，目标价从11美元升至13美元
07-22 11:35
美股大行评级 | 台积电、联合健康、美国合众银行获多家大行上调目标价；奈飞、直觉外科遭数十家大行下调目标价
今日重点评级关注：摩根大通：维持联合大陆航空"超配"评级，目标价从156美元升至203美元；摩根士丹利：维持联合大陆航空"超配"评级，目标价从185美元升至190美元
07-20 13:49
UBS Maintains Neutral on Lineage, Raises Price Target to $45
UBS analyst Michael Goldsmith maintains Lineage (NASDAQ:LINE) with a Neutral and raises the price target from $35 to $45.
07-17 20:46
